Home › Burkitt Lymphoma › Alaska › Anchorage
Burkitt Lymphoma clinical trials in Anchorage, AK
3 studies for Burkitt Lymphoma are looking for participants at sites in and around Anchorage (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RecruitingPhase 2
- Providence Alaska Medical Center, Anchorage
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RecruitingPhase 2
- Providence Alaska Medical Center, Anchorage
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RecruitingPhase 3
- Providence Alaska Medical Center, Anchorage
Burkitt Lymphoma trials in other cities
- Houston, TX20 studies
- Milwaukee, WI16 studies
- Chicago, IL15 studies
- Philadelphia, PA15 studies
- Seattle, WA14 studies
- Atlanta, GA13 studies
- New York City, NY13 studies
- Cincinnati, OH13 studies
- Los Angeles, CA10 studies
- Baldwin Park, CA10 studies
- Aurora, CO10 studies
- Durham, NC10 studies
Other studies in Anchorage
- Non-Small Cell Lung Cancer10 studies
- Lung Cancer8 studies
- Breast Cancer7 studies
- Ovarian Cancer7 studies
- Prostate Cancer5 studies
- Pancreatic Cancer4 studies
- Endometrial Cancer4 studies
- Cancer (all types)3 studies
- Acute Biphenotypic Leukemia3 studies
- Melanoma3 studies
- Esophageal Adenocarcinoma3 studies
- Stomach Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.